PDCD1 and hepatocellular carcinoma: Based on our long-term clinical practice, the present study aims to report the outcomes of a cohort of patients with initially unresectable HCC with PVTT who underwent combination therapy of TKIs plus PD-1 inhibitors and salvage surgery, as well as to summarize the surgical experience, particularly in the management of PVTT.